AAFPRS President Addresses Concerns About Moderna COVID-19 Vaccine
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
AAFPRS will continue monitoring reports of incidents of reactions in patients with dermal fillers who received the Moderna COVID-19 vaccine.
Federal health officials say the society’s stance aligns with evidence showing low certainty and unclear risk-benefit for gender-related endocrine and surgical interventions in children and adolescents.